Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Leukocyte Biology|May 4, 2007
TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsetsM Pyzik, C A PiccirilloHuman Gene Therapy|August 31, 1999
Prevention of experimental allergic encephalomyelitis by intramuscular gene transfer with cytokine-encoding plasmid vectorsC A Piccirillo, G J Prud'hommeJournal of Autoimmunity|January 29, 2000
The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseasesG J Prud'homme, C A PiccirilloJournal of Immunology (Baltimore, Md. : 1950)|July 24, 2001
Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cellsC A Piccirillo, E M ShevachJournal of Immunology (Baltimore, Md. : 1950)|October 21, 1998
TGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic miceC A Piccirillo, Y Chang, G J Prud'hommeClinical and Experimental Immunology|March 14, 2019
Mechanisms of human FoxP3+ Treg cell development and function in health and diseaseM Attias, T Al-Aubodah, C A PiccirilloAutoimmunity|May 25, 2011
Transfer of cell membrane components via trogocytosis occurs in CD4+ Foxp3+ CD25+ regulatory T-cell contact-dependent suppressionD Bahcheli, V Hay, J L Nadeau, et al.Immunological Reviews|November 28, 2001
Control of T-cell activation by CD4+ CD25+ suppressor T cellsE M Shevach, R S McHugh, C A Piccirillo, et al.Annals of the New York Academy of Sciences|August 30, 2005
Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD miceC A Piccirillo, M Tritt, E Sgouroudis, et al.Neoplasia (New York, N.Y.)|January 13, 2023
S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomasA Mehdi, M Attias, A Arakelian, et al.Pageof 2